Healthcare Services Performance (Median, IQR) | Accredited n = 1 (10%) | Non-Accredited Public n = 5 (50%) | P-Value | Accredited n = 1 (10%) | Non-Accredited PNFP n = 4 (40%) | P-Value | Non-Accredited Public n = 5 (50%) | Non-Accredited PNFP n = 4 (40%) | P-Value |
HIV | |||||||||
 New clients on ART per 100 pop | 0.34 (0.33–0.39) | 0.19 (0.12–0.26) | 0.028* | 0.34 (0.33–0.39) | 0.13 (0.09–0.18) | 0.001* | 0.19 (0.12–0.26) | 0.13 (0.09–0.18) | 0.025* |
 DOS-TDF/3TC/DTG | 3.00 (1.00–16.00) | 0.00 (0.00–0.00) | 0.085 | 3.00 (1.00–16.00) | 0.00 (0.00–0.00) | 0.002* | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.177 |
 DOS-ABC/3TC | 1.00 (0.00–14.00) | 0.00 (0.00–0.000) | 0.010* | 1.00 (0.00–14.00) | 0.00 (00.0–0.00) | 0.001* | 0.00 (0.00–0.000) | 0.00 (00.0–0.00) | 0.218 |
 DOS-determine test kits | 0.00 (0.00–0.00) | 0.00 (0.00–11.00) | 0.143 | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.511 | 0.00 (0.00–11.00) | 0.00 (0.00–0.00) | 0.028* |
 DOS-Stat Pak test kits | 0.00 (0.00–0.00) | 0.0 (0.00–30.00) | 0.186 | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.402 | 0.0 (0.00–30.00) | 0.00 (0.00–0.00) | 0.138 |
TB | |||||||||
 Cases identified per 100 pop | 0.33 (0.18–0.48) | 0.17 (0.09–0.25) | 0.132 | 0.33 (0.18–0.48) | 0.04 (0.01–0.12) | 0.006* | 0.17 (0.09–0.25) | 0.04 (0.01–0.12) | 0.001* |
 Cases diagnosed per 100 pop | 0.30 (0.20–0.36) | 0.04 (0.03–0.08) | 0.001* | 0.30 (0.20–0.36) | 0.02 (0.01–0.02) | 0.001* | 0.04 (0.03–0.08) | 0.02 (0.01–0.02) | 0.000* |
 Cases enrolled per 100 pop | 0.20 (0.09–0.41) | 0.04 (0.03–0.10) | 0.009* | 0.20 (0.09–0.41) | 0.01 (0.01–0.03) | 0.001* | 0.04 (0.03–0.10) | 0.01 (0.01–0.03) | 0.003* |
 DOS-GeneXpert cartridges | 0.00 (0.00–30.00) | 31.00 (30.00–60.00) | 0.066 | 0.00 (0.00–30.00) | 0.00 (0.00–15.00) | 0.731 | 31.00 (30.00–60.00) | 0.00 (0.00–15.00) | 0.059 |
Malaria per 100 pop | |||||||||
 Cases identified | 1.16 (0.64–1.43) | 1.16 (0.62–2.13) | 0.552 | 1.16 (0.64–1.43) | 0.23 (0.13–0.36) | 0.005* | 1.16 (0.62–2.13) | 0.23 (0.13–0.36) | 0.000* |
 Cases diagnosed | 1.11 (0.60–1.37) | 1.07 (0.62–2.02) | 0.511 | 1.11 (0.60–1.37) | 0.22 (0.13–0.36) | 0.005* | 1.07 (0.62–2.02) | 0.22 (0.13–0.36) | 0.000* |
Laboratory Services per 100 pop | |||||||||
 Referral samples | 5.01 (3.18–7.76) | 0.29 (0.18–0.67) | 0.050 | 5.01 (3.18–7.76) | 0.67 (0.35–1.72) | 0.041* | 0.29 (0.18–0.67) | 0.67 (0.35–1.72) | 0.540 |
 Hep B Testing | 3.21 (2.21–5.80) | 3.45 (0.35–5.16) | 0.737 | 3.21 (2.21–5.80) | 0.88 (0.54–1.43) | 0.081 | 3.45 (0.35–5.16) | 0.88 (0.54–1.43) | 0.121 |
MCH services per 1000 pop | |||||||||
 Maternity Admissions | 1.08 (1.06–1.13) | 0.17 (0.09–0.21) | 0.000* | 1.08 (1.06–1.13) | 0.12 (0.10–0.14) | 0.000* | 0.17 (0.09–0.21) | 0.12 (0.10–0.14) | 0.028* |
 Maternity deliveries | 0.73 (0.69–0.77) | 0.15 (0.07–0.17) | 0.000* | 0.73 (0.69–0.77) | 0.09 (0.06–0.11) | 0.000* | 0.15 (0.07–0.17) | 0.09 (0.06–0.11) | 0.003* |
 BCG immunisation | 0.86 (0.79–0.87) | 0.24 (0.09–0.28) | 0.001* | 0.86 (0.79–0.87) | 0.09 (0.07–0.15) | 0.001* | 0.24 (0.09–0.28) | 0.09 (0.07–0.15) | 0.006* |
 Pentavalent immunisation | 0.42 (0.38–0.45) | 0.23 (0.09–0.27) | 0.020* | 0.42 (0.38–0.45) | 0.08 (0.05–0.19) | 0.001* | 0.23 (0.09–0.27) | 0.08 (0.05–0.19) | 0.002* |
 Deworming | 0.26 (0.25–0.67) | 0.56 (0.09–2.51) | 0.770 | 0.26 (0.25–0.67) | 0.11 (0.02–0.59) | 0.221 | 0.56 (0.09–2.51) | 0.11 (0.02–0.59) | 0.081 |
Healthcare Services Performance (Median, IQR) | Accredited (n = 1) | Non-Accredited Public (n = 5) | P-Value | Accredited (n = 1) | Non-Accredited PNFP (n = 4) | P-Value | Non-Accredited Public (n = 5) | Non-Accredited PNFP (n = 4) | P-Value |
Reporting to dhis-2 | |||||||||
 hmis 105:01 (attendances, referrals) | 61.15 (47.20–66.7) | 33.30 (33.30–33.30) | 0.008* | 61.15 (47.20–66.7) | 33.30 (33.30–33.30) | 0.000* | 33.30 (33.30–33.30) | 33.30 (33.30–33.30) | 0.007* |
 hmis 105:10 (laboratory) | 38.85 (24.98–44.40) | 33.30 (33.00–33.00) | 0.980 | 38.85 (24.98–44.40) | 33.30 (33.30–33.30) | 0.294 | 33.30 (33.00–33.00) | 33.30 (33.30–33.30) | 0.025* |